Johnson & Johnson (JNJ)

137.52
1.00 0.72
NYSE
Prev Close 138.52
Open 139.35
Day Low/High 135.75 / 140.24
52 Wk Low/High 118.62 / 148.99
Volume 10.49M
Exchange NYSE
Shares Outstanding 2662.77B
Market Cap 368.85B
Div & Yield N.A. (N.A)
Rev's Forum: Traders Would Love to Trade In This Vexing Market

Rev's Forum: Traders Would Love to Trade In This Vexing Market

It is a very muddled market, and that demands that we stay patient and wait for greater clarity to develop.

Today's Takeaways and Observations (3PM Edition)

I spent a lot of time on the (respectful) Rosenberg/Kass debate on economic growth and interest rates today:   * And Now A Word From Dennis Rosenberg  * And Now A Word From Dennis Rosenberg (Part Deux)  * And the Rosenberg Empire Strikes Again  * Ju...

Cramer: We Need Leadership

Cramer: We Need Leadership

As markets yo-yo, both bulls and bears are left seeking leadership.

Rev's Forum: It's a Mediocre Market, but Bears Can't Close the Deal

Rev's Forum: It's a Mediocre Market, but Bears Can't Close the Deal

Despite a long list of negatives, the ursine class has been unable to push the market into a full-blown downtrend.

Closing Bell: Wall Street Closes Lower After First Quarter Earnings Drag Down Markets

Closing Bell: Wall Street Closes Lower After First Quarter Earnings Drag Down Markets

Stocks closed lower after digesting mixed first quarter earnings data.

Is the Market Delaying the Inevitable?

Is the Market Delaying the Inevitable?

Bulls are standing in the way of a needed correction.

Feeling The Market's Pain

"It is always by way of pain one arrives at pleasure." - Marquis de Sade   Today's Dow Jones decline is the worst since March 21, 2017 -- pulled down materially by weakness in Johnson & Johnson and Goldman Sachs . Stocks are down for the fourth day ...

Midday Report: Stocks See Red as Financials, Health Care Sectors Drag Markets Lower

Midday Report: Stocks See Red as Financials, Health Care Sectors Drag Markets Lower

Stock extend losses as Goldman Sachs and Johnson & Johnson lead the Dow lower.

Watching Pullbacks for an Entry

Watching Pullbacks for an Entry

I'm keeping an eye out, but there isn't enough support to suggest that now is the time to start buying.

This Could Be Apple's Greatest Innovation

This Could Be Apple's Greatest Innovation

Apple's reported move into bio sensors could lead to even greater heights.

Cramer: Without an Economic Win, We Are Hostage to Oil

Cramer: Without an Economic Win, We Are Hostage to Oil

Repatriation of profits would bring in money and tax revenue.

Global Financial News: Investors Grapple With Active Week in the U.S. Calendar

Global Financial News: Investors Grapple With Active Week in the U.S. Calendar

Your round-up of the financial news from around the world.

What to Watch Tuesday: Goldman Sachs, Bank of America Report Earnings

What to Watch Tuesday: Goldman Sachs, Bank of America Report Earnings

Goldman Sachs and Bank of America release earnings on Tuesday.

Avoid the 'Spring Slump' With These Big, Outperforming Stocks

Avoid the 'Spring Slump' With These Big, Outperforming Stocks

These four stocks are showing short-term gain catalysts and longer-term growth potential.

The Good, the Bad and the Ugly (Mid-Afternoon Edition)

"It's not a joke, it's a rope, Tuco. Now I want you to get up there and put your head in that noose." -- Blondie, " The Good, the Bad and the Ugly" No "Takeaways" today as its vacation time at the Kass household and I want to take a swim with my fam...

Cramer: Stay the Course, but Keep Cash Handy

Cramer: Stay the Course, but Keep Cash Handy

It's pretty normal to have profit-taking after such a strong first quarter.

Cramer: We Have Nothing to Distinguish the Stocks Right Now

Cramer: We Have Nothing to Distinguish the Stocks Right Now

We know that we are in the era when index managers are ascendant.

Less Bang for the Buck? No Problem

Less Bang for the Buck? No Problem

Weaker dollar may not be bad for Boeing, Johnson & Johnson and Procter & Gamble.

Takeaways and Observations

Let me teach you how to Dougie. Consumer confidence is a coincident/lagging indicator. And excitement over the print, is (quite frankly) "first level thinking." As support, check out these two charts of the day -- it's "second level thinking." Snap ...

More Companies Pull Advertising to Protest Google's Treatment of Extremist Content

More Companies Pull Advertising to Protest Google's Treatment of Extremist Content

Britain is the second largest market for Google, generating $7.8 billion primarily from advertising in 2016.

These 3 Would Look Great at Lower Prices

These 3 Would Look Great at Lower Prices

If opportunity knocks, I'm buying.

Health Care Companies Could Be Active Today as Congress Votes

Health Care Companies Could Be Active Today as Congress Votes

The GOP is scrambling for votes on Obamacare Repeal.

Takeaways & Observations

"I had nothing to offer anybody except my own confusion." -- Jack Kerouac  So, color me confused. But I will persevere and write "Takeaways!"  While a lot didn't make sense, I suspect many traders/investors were caught "offsides."  Peter Boockvar do...

Health Care Putting in a Base

Healthcare stocks had a heckuva four-year period of over-performance that ended in the summer of 2015. Since then the Health Care Select Sector SPDR ETF (40% pharma and 15% biotech) has had a series of trading-range moves as sector prices lagged. La...

Cramer: Top 10 Bull Markets Right Now

Cramer: Top 10 Bull Markets Right Now

Bull market number one, perhaps of all time: the financials.

Tech Stocks Under Trump

Tech Stocks Under Trump

They might have an issue with corporate tax reform.

Cramer: This Drug Rally Is No Longer 'Trumped Up'

Cramer: This Drug Rally Is No Longer 'Trumped Up'

Let's recognize that some moves are simply related to bonds, which are in the grips of a bizarre developed-world shortage.

Cramer: Money's Being Thrown at Almost Everything in the Market

Cramer: Money's Being Thrown at Almost Everything in the Market

There are nearly too many surging sectors to count.

What Jim Cramer Expects From Valeant Pharmaceuticals' Results on Tuesday

What Jim Cramer Expects From Valeant Pharmaceuticals' Results on Tuesday

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer is keeping an eye on quarterly results from Valeant Pharmaceuticals on Tuesday.

Cramer: When Someone Calls a Market Top, What's Their Motivation?

Cramer: When Someone Calls a Market Top, What's Their Motivation?

It's better to be early than wrong. Though being wrong isn't so awful.